Sunday, January 31, 2021

Granules arm gets American health regulator's nod for Potassium Chloride Oral Solution

In a BSE filing, Granules said the US Food and Drug Administration
(USFDA) has approved the abbreviated new drug application (ANDA) filed
by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign
subsidiary of Granules India Ltd, for Potassium Chloride Oral Solution
USP.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-arm-gets-american-health-regulators-nod-for-potassium-chloride-oral-solution/articleshow/80624250.cms

No comments:

Post a Comment